Economic Burden of HIV Antiretroviral Therapy Adverse Events in the United States

Economic Burden of HIV Antiretroviral Therapy Adverse Events in the United States

Objective: To estimate health care costs associated with medical events identified as antiretroviral therapy (ART)-attributable adverse events (AEs). Methods: During September 2006 to June 2012, adults with ≥1 HIV International Classification of Diseases, Ninth Revision, Clinical Modification diagno...

Full description

Bibliographic Details
Main Authors:	Mitch Dekoven MHSA, Charles Makin BSPharm, MS, MBA, MM, Samantha Slaff MS, Michael Marcus MAS, Eric M. Maiese PhD
Format:	Article
Language:	English
Published:	SAGE Publishing 2016-01-01
Series:	Journal of the International Association of Providers of AIDS Care
Online Access:	https://doi.org/10.1177/2325957415594883

Similar Items

Cost per Episode of Care With Collagenase Clostridium histolyticum Versus Fasciectomy for Dupuytren Contracture: A Real-World Claims Database Analysis
by: Stephen B. Camper, MS, PhD, et al.
Published: (2019-04-01)

Factors associated with the occurrence of adverse events to antiretroviral therapy in adults and elderly living with HIV
by: Thaís Lorenna Souza Sales, et al.
Published: (2021-08-01)

The economic burden of CIDP in the United States: A case-control study.
by: Victoria Divino, et al.
Published: (2018-01-01)

Incidence and determinants of adverse events in individuals with HIV commencing Dolutegravir-based antiretroviral therapy in mainland Tanzania
by: Adam Fimbo, et al.
Published: (2024-01-01)

Adverse events in Chinese human immunodeficiency virus (HIV) patients receiving first line antiretroviral therapy
by: Lili Dai, et al.
Published: (2020-02-01)

Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIV.
by: N Chantal Peltenburg, et al.
Published: (2018-01-01)

Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole
by: Phoorisri Thanongsri, et al.
Published: (2007-03-01)

Caregiver's burden of children living with HIV on antiretroviral therapy at an urban setup
by: Shivangi Ashvinbhai Inamdar, et al.
Published: (2021-01-01)

Patient Reported Central Nervous System Adverse Events of Efavirenz-Based Antiretroviral Therapy in People Living with HIV in Northwest Ethiopia
by: Muche EA, et al.
Published: (2020-10-01)

Impact of adverse events of antiretroviral treatment on regimen change and mortality in Ugandan children
by: Ntambwe Malangu, et al.
Published: (2010-06-01)

Control of adverse drug reactions in HIV/AIDS antiretroviral treatment with interchangeable medicines
by: M. V. Zhuravleva, et al.
Published: (2018-02-01)

Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication.
by: Erika Aaron, et al.
Published: (2010-01-01)

Frequency of adverse events associated to antiretroviral drugs in patients starting therapy in Salvador, Brazil
by: Ornela Vendruscolo, et al.
Published: (2015-01-01)

HIV and antiretroviral treatment knowledge gaps and psychosocial burden among persons living with HIV in Lima, Peru.
by: Rafaella Navarro, et al.
Published: (2021-01-01)

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study
by: Prosperi Mattia CF, et al.
Published: (2012-11-01)

The financial burden of morbidity in HIV-infected adults on antiretroviral therapy in Côte d'Ivoire.
by: Arnousse Beaulière, et al.
Published: (2010-06-01)

Burden of fatigue among adults living with HIV/AIDS attending antiretroviral therapy in Ethiopia
by: Tsiwaye Gebreyesus, et al.
Published: (2020-04-01)

Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case review.
by: Christiana Smith, et al.
Published: (2015-01-01)

What Are Adverse Events in Mindfulness Meditation?
by: Dhanesh D. Binda BS, et al.
Published: (2022-04-01)

Neuropsychiatric Adverse Events Following Antiretroviral Therapy in People Living with HIV: A Real-World Study of Dynamic Trends and Risk Factors in Hangzhou, China
by: Zhang W, et al.
Published: (2023-08-01)

Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era
by: Emily eAdland, et al.
Published: (2015-09-01)

Presentation and outcome of suspected sepsis in a high-HIV burden, high antiretroviral coverage setting
by: Wendy Chaka, et al.
Published: (2020-07-01)

“Lighten This Burden of Ours”: Acceptability and Preferences Regarding Injectable Antiretroviral Treatment Among Adults and Youth Living With HIV in Coastal Kenya
by: Jane M. Simoni PhD, et al.
Published: (2021-03-01)

Hepatic adverse events during highly active antiretroviral therapy containing nevirapine: a case report
by: Yamazhan Tansu, et al.
Published: (2002-09-01)

Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire
by: Amani-Bosse Clarisse, et al.
Published: (2010-06-01)

Antiretroviral Therapy Protects against Frailty in HIV-1 Infection
by: Voichita Ianas MD, et al.
Published: (2013-02-01)

Antiretroviral regimens for preventing HIV infection in infants
by: René E. Ekpini, et al.
Published: (2005-07-01)

Adverse effects of antiretroviral therapy or another disease?
by: Mariana Stanescu, et al.
Published: (2020-09-01)

Antiretroviral Treatment Scale-Up and Tuberculosis Mortality in High TB/HIV Burden Countries: An Econometric Analysis.
by: Isabel Yan, et al.
Published: (2016-01-01)

Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials
by: Jennifer G. Le-Rademacher, et al.
Published: (2020-11-01)

Improving Spatial Accessibility to Antiretroviral Treatments for HIV/AIDS
by: Carr, Christopher Charles, et al.
Published: (2016)

HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy
by: F. Harrison Omondi, et al.
Published: (2021-12-01)

Identifying Patterns of Adverse Events of Solid Organ Transplantation Through Departmental Case Reviews
by: Amit K. Mathur, MD, MS, et al.
Published: (2019-09-01)

A comparison of nurses’ and physicians’ perception of cancer treatment burden based on reported adverse events
by: Shing M. Lee, et al.
Published: (2019-08-01)

Progression of coronary atherosclerotic plaque burden and relationship with adverse cardiovascular event in asymptomatic diabetic patients
by: Junjie Yang, et al.
Published: (2019-02-01)

Adverse perinatal outcomes associated with antiretroviral therapy in women living with HIV: a systematic review and meta-analysis
by: Portwood, C, et al.
Published: (2023)

Adverse perinatal outcomes associated with antiretroviral therapy in women living with HIV: A systematic review and meta-analysis
by: Clara Portwood, et al.
Published: (2023-02-01)

Adherence to antiretroviral therapy and correlation with adverse effects and coinfections in people living with HIV/AIDS in the municipality of Goiás State
by: Luane da Silva Oliveira, et al.

Adverse effects in children exposed to maternal HIV and antiretroviral therapy during pregnancy in Brazil: a cohort study
by: Adriane M. Delicio, et al.
Published: (2018-05-01)

Validation of a Short Adherence Questionnaire for Children Living with HIV on Antiretroviral Therapy in Kenya
by: Rachel Christine Vreeman MD, MS, et al.
Published: (2018-12-01)